Cargando…
Case report: A case of duodenal adenocarcinoma achieving significantly long survival treating with immune checkpoint inhibitors and chemotherapy without positive biomarkers
Small bowel adenocarcinoma (SBA), particularly duodenal adenocarcinoma (DA), is a rare gastrointestinal cancer with a dismal prognosis. Data on SBA treatments are limited, and the therapeutic strategy remains uncertain. Currently, chemotherapy is the most used treatment; however, it has a poor media...
Autores principales: | Chen, Xian, Zhou, Rui, Li, Yong, Qu, Xin, Qu, Yan-chun, Li, Wen-zhu, Ye, Yong-song, Liu, Li-rong, Zhu, Yan-juan, Zhang, Hai-bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755197/ https://www.ncbi.nlm.nih.gov/pubmed/36531985 http://dx.doi.org/10.3389/fimmu.2022.1046513 |
Ejemplares similares
-
Neoadjuvant chemotherapy in locally advanced duodenal adenocarcinoma
por: Velandia, Carlos, et al.
Publicado: (2018) -
Pancreatoduodenectomy following neoadjuvant chemotherapy in duodenal adenocarcinoma
por: Seo, Dongjin, et al.
Publicado: (2023) -
A rare case of duodenal adenocarcinoma
por: Tuan, Ho Xuan, et al.
Publicado: (2023) -
The prognostic significance of duodenal wall invasion in pancreatic adenocarcinoma
por: Alkhasawneh, Ahmad, et al.
Publicado: (2023) -
Rare resected eight cases of duodenal adenocarcinomas
por: Nanashima, Atsushi, et al.
Publicado: (2021)